Palvella Therapeutics PVLA Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Palvella Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: Palvella Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Palvella Therapeutics's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Palvella Therapeutics's retained earnings?
- Palvella Therapeutics (PVLA) reported retained earnings of -$151.22M in Q1 2026.
- How has Palvella Therapeutics's retained earnings changed year-over-year?
- Palvella Therapeutics's retained earnings decreased by 48.4% year-over-year, from -$101.92M to -$151.22M.
- What is the long-term trend for Palvella Therapeutics's retained earnings?
- Over 5 years (2020 to 2025), Palvella Therapeutics's retained earnings has grown at a -8.5% compound annual growth rate (CAGR), from -$211.41M to -$135.45M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.